Category: CovidienSyndicate content

FDA clears Stryker's Trevo clot retriever

August 13, 2012 by MassDevice staff

Stryker Corp.'s Trevo medical device, designed to retrieve the blood clots that cause ischemic strokes.

Stryker Corp.

The FDA granted 510(k) clearance for Stryker's (NYSE:SYK) Trevo Pro blood clot retriever, technology it acquired along with Concentric Medical in 2011.

The medical device company said the stroke treatment device is the latest iteration of its Trevo line, designed to remove the blood clots that cause ischemic stroke.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Med-tech trends: The most talked about medical device companies for July 2012

August 3, 2012 by MassDevice staff

MassDevice.com looks at the internet chatter surrounding the medical device industry with some of most searched-for companies of the last month.

chart

Click to enlarge.

MassDevice.com looked at some of the most talked-about medical device companies, based on trends in U.S. Google searches for the last 30 days.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien cuts the ribbon on $45M R&D center in China

August 2, 2012 by MassDevice staff

Covidien's new $45 million Shanghai research & development aligns with the medical device company's 5-year strategy in emerging markets.

Covidien logo

Covidien (NYSE:COV) cut the ribbon on its brand Chinese research & development center, planning to invest $45 million and employ more than 300 workers over the course of 3 years.

The China Technology Center R&D facility, a 1st for the company, helps the medical device company bolster its strategic growth initiatives for China and other emerging markets, as outlined in Covidien's 5-year plan.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

MassDevice.com +3 | The top 3 med-tech stories for July 31, 2012

July 31, 2012 by MassDevice staff

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

Covidien makes a small round of job cuts connected to Newport buyout | Personnel Moves

July 31, 2012 by MassDevice staff

Medical device company Covidien cuts about 24 jobs from its Respiratory & Monitoring Solutions Unit, connected to its Newport Medical Instruments acquisition.

fired/hired

Covidien (NYSE:COV) made a small round of job cuts in association with the medical device company's acquisition of Newport Medical Instruments.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

FDA clears Covidien's latest Nellcor continuous respiratory monitor

July 30, 2012 by MassDevice staff

Covidien wins FDA clearance for its Nellcor Bedside SpO2 patient monitoring system with continuous monitoring.

Covidien logo

Medical device maker Covidien (NYSE:COV) touted FDA clearance for the latest in its line of Nellcor patient monitors, the Bedside SpO2.

The device continuously monitors SpO2 and pulse rate for adult, pediatric and neonatal patients, providing access to comprehensive respiratory trends and subtle variations.

Get the complete picture with a MassDevice Plus membership. Registered users can login here.

MassDevice.com +3 | The top 3 med-tech stories for July 26, 2012

July 26, 2012 by MassDevice staff

Plus 3

Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This feature of MassDevice.com's coverage highlights our 3 biggest and most influential stories from the day's news to make sure you're up to date on the headlines that continue to shape the medical device industry.

If you read nothing else today, make sure you're still in the know with MassDevice +3.

Built on an AdaptiveTheme using Drupal by Michael Knapp  mknapp